Provided by Tiger Fintech (Singapore) Pte. Ltd.

Globus Medical

73.07
+1.281.78%
Post-market: 73.070.00000.00%18:03 EDT
Volume:698.81K
Turnover:51.01M
Market Cap:10.05B
PE:97.43
High:73.63
Open:71.75
Low:71.33
Close:71.79
Loading ...

Company Profile

Company Name:
Globus Medical
Exchange:
NYSE
Establishment Date:
2003
Employees:
5300
Office Location:
2560 General Armistead Avenue,Audubon,Pennsylvania,United States
Zip Code:
19403
Fax:
- -
Introduction:
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Directors

Name
Position
David C. Paul
Executive Chairman
David M. Demski
Director and Chief Executive Officer
Kurt C. Wheeler
Lead Independent Director
Ann D. Rhoads
Director
Daniel T. Lemaitre
Director
David D. Davidar
Director
James R. Tobin
Director
Robert W. Liptak
Director

Shareholders

Name
Position
David M. Demski
Director and Chief Executive Officer
Daniel T. Scavilla
Senior Vice President and Chief Financial Officer
Eric I. Schwartz
Senior Vice President and General Counsel
A. Brett Murphy
Executive Vice President, International Sales
Anthony L. Williams
President
David C. Paul
Executive Chairman